IBDEI07G ; ; 18-FEB-2009
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 18, 2009
 Q:'DIFQR(358.3)  F I=3D1:2 S X=3D$T(Q+I) Q:X=3D""  S
Y=3D$E($T(Q+I+1),4,999),X=3D$E(X,4,999) S:$A(Y)=3D126
I=3DI+1,Y=3D$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=3D61 Y=3D$E(Y,2,999) =
X NO E
S @X=3DY
Q Q
 ;;^UTILITY(U,$J,358.3,7925,2)
 ;;=3D^295309
 ;;^UTILITY(U,$J,358.3,7926,0)
 ;;=3DV19.0^^65^553^8
 ;;^UTILITY(U,$J,358.3,7926,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7926,1,4,0)
 ;;=3D4^V19.0
 ;;^UTILITY(U,$J,358.3,7926,1,5,0)
 ;;=3D5^Family h/o Blindness
 ;;^UTILITY(U,$J,358.3,7926,2)
 ;;=3D^295320
 ;;^UTILITY(U,$J,358.3,7927,0)
 ;;=3DV16.3^^65^553^9
 ;;^UTILITY(U,$J,358.3,7927,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7927,1,4,0)
 ;;=3D4^V16.3
 ;;^UTILITY(U,$J,358.3,7927,1,5,0)
 ;;=3D5^Family h/o Cancer of Breast
 ;;^UTILITY(U,$J,358.3,7927,2)
 ;;=3D^295295
 ;;^UTILITY(U,$J,358.3,7928,0)
 ;;=3DV16.41^^65^553^12
 ;;^UTILITY(U,$J,358.3,7928,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7928,1,4,0)
 ;;=3D4^V16.41
 ;;^UTILITY(U,$J,358.3,7928,1,5,0)
 ;;=3D5^Family h/o Cancer of Ovary
 ;;^UTILITY(U,$J,358.3,7928,2)
 ;;=3D^317951
 ;;^UTILITY(U,$J,358.3,7929,0)
 ;;=3DV16.42^^65^553^13
 ;;^UTILITY(U,$J,358.3,7929,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7929,1,4,0)
 ;;=3D4^V16.42
 ;;^UTILITY(U,$J,358.3,7929,1,5,0)
 ;;=3D5^Family h/o Cancer of Prostate
 ;;^UTILITY(U,$J,358.3,7929,2)
 ;;=3D^317952
 ;;^UTILITY(U,$J,358.3,7930,0)
 ;;=3DV16.43^^65^553^14
 ;;^UTILITY(U,$J,358.3,7930,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7930,1,4,0)
 ;;=3D4^V16.43
 ;;^UTILITY(U,$J,358.3,7930,1,5,0)
 ;;=3D5^Family h/o Cancer of Testis
 ;;^UTILITY(U,$J,358.3,7930,2)
 ;;=3D^317953
 ;;^UTILITY(U,$J,358.3,7931,0)
 ;;=3DV19.5^^65^553^15
 ;;^UTILITY(U,$J,358.3,7931,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7931,1,4,0)
 ;;=3D4^V19.5
 ;;^UTILITY(U,$J,358.3,7931,1,5,0)
 ;;=3D5^Family h/o Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,7931,2)
 ;;=3D^295325
 ;;^UTILITY(U,$J,358.3,7932,0)
 ;;=3DV19.2^^65^553^16
 ;;^UTILITY(U,$J,358.3,7932,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7932,1,4,0)
 ;;=3D4^V19.2
 ;;^UTILITY(U,$J,358.3,7932,1,5,0)
 ;;=3D5^Family h/o Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,7932,2)
 ;;=3D^295322
 ;;^UTILITY(U,$J,358.3,7933,0)
 ;;=3DV17.3^^65^553^18
 ;;^UTILITY(U,$J,358.3,7933,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7933,1,4,0)
 ;;=3D4^V17.3
 ;;^UTILITY(U,$J,358.3,7933,1,5,0)
 ;;=3D5^Family h/o Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,7933,2)
 ;;=3D^295305
 ;;^UTILITY(U,$J,358.3,7934,0)
 ;;=3DV16.6^^65^553^19
 ;;^UTILITY(U,$J,358.3,7934,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7934,1,4,0)
 ;;=3D4^V16.6
 ;;^UTILITY(U,$J,358.3,7934,1,5,0)
 ;;=3D5^Family h/o Leukemia
 ;;^UTILITY(U,$J,358.3,7934,2)
 ;;=3D^295298
 ;;^UTILITY(U,$J,358.3,7935,0)
 ;;=3DV18.61^^65^553^21
 ;;^UTILITY(U,$J,358.3,7935,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7935,1,4,0)
 ;;=3D4^V18.61
 ;;^UTILITY(U,$J,358.3,7935,1,5,0)
 ;;=3D5^Family h/o Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,7935,2)
 ;;=3D^321531
 ;;^UTILITY(U,$J,358.3,7936,0)
 ;;=3DV17.0^^65^553^22
 ;;^UTILITY(U,$J,358.3,7936,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7936,1,4,0)
 ;;=3D4^V17.0
 ;;^UTILITY(U,$J,358.3,7936,1,5,0)
 ;;=3D5^Family h/o Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,7936,2)
 ;;=3D^295302
 ;;^UTILITY(U,$J,358.3,7937,0)
 ;;=3DV19.4^^65^553^23
 ;;^UTILITY(U,$J,358.3,7937,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7937,1,4,0)
 ;;=3D4^V19.4
 ;;^UTILITY(U,$J,358.3,7937,1,5,0)
 ;;=3D5^Family h/o Skin Condition
 ;;^UTILITY(U,$J,358.3,7937,2)
 ;;=3D^295324
 ;;^UTILITY(U,$J,358.3,7938,0)
 ;;=3DV17.1^^65^553^24
 ;;^UTILITY(U,$J,358.3,7938,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7938,1,4,0)
 ;;=3D4^V17.1
 ;;^UTILITY(U,$J,358.3,7938,1,5,0)
 ;;=3D5^Family h/o Stroke (Cerebrovascular)
 ;;^UTILITY(U,$J,358.3,7938,2)
 ;;=3D^295303
 ;;^UTILITY(U,$J,358.3,7939,0)
 ;;=3DV16.8^^65^553^20
 ;;^UTILITY(U,$J,358.3,7939,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7939,1,4,0)
 ;;=3D4^V16.8
 ;;^UTILITY(U,$J,358.3,7939,1,5,0)
 ;;=3D5^Family h/o Other Specified Cancer
 ;;^UTILITY(U,$J,358.3,7939,2)
 ;;=3D^295300
 ;;^UTILITY(U,$J,358.3,7940,0)
 ;;=3DV11.1^^65^553^44
 ;;^UTILITY(U,$J,358.3,7940,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7940,1,4,0)
 ;;=3D4^V11.1
 ;;^UTILITY(U,$J,358.3,7940,1,5,0)
 ;;=3D5^Personal h/o Affective Disorder
 ;;^UTILITY(U,$J,358.3,7940,2)
 ;;=3D^295250
 ;;^UTILITY(U,$J,358.3,7941,0)
 ;;=3DV15.89^^65^553^52
 ;;^UTILITY(U,$J,358.3,7941,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7941,1,4,0)
 ;;=3D4^V15.89
 ;;^UTILITY(U,$J,358.3,7941,1,5,0)
 ;;=3D5^Personal h/o Exposure To Persian Gulf Region
 ;;^UTILITY(U,$J,358.3,7941,2)
 ;;=3D^295291
 ;;^UTILITY(U,$J,358.3,7942,0)
 ;;=3DV11.3^^65^553^45
 ;;^UTILITY(U,$J,358.3,7942,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7942,1,4,0)
 ;;=3D4^V11.3
 ;;^UTILITY(U,$J,358.3,7942,1,5,0)
 ;;=3D5^Personal h/o Alcoholism
 ;;^UTILITY(U,$J,358.3,7942,2)
 ;;=3D^295252
 ;;^UTILITY(U,$J,358.3,7943,0)
 ;;=3DV15.07^^65^553^46
 ;;^UTILITY(U,$J,358.3,7943,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7943,1,4,0)
 ;;=3D4^V15.07
 ;;^UTILITY(U,$J,358.3,7943,1,5,0)
 ;;=3D5^Personal h/o Allerlgy to Latex
 ;;^UTILITY(U,$J,358.3,7943,2)
 ;;=3D^322043
 ;;^UTILITY(U,$J,358.3,7944,0)
 ;;=3DV13.4^^65^553^47
 ;;^UTILITY(U,$J,358.3,7944,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7944,1,4,0)
 ;;=3D4^V13.4
 ;;^UTILITY(U,$J,358.3,7944,1,5,0)
 ;;=3D5^Personal h/o Arthritis
 ;;^UTILITY(U,$J,358.3,7944,2)
 ;;=3D^295267
 ;;^UTILITY(U,$J,358.3,7945,0)
 ;;=3DV12.72^^65^553^48
 ;;^UTILITY(U,$J,358.3,7945,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7945,1,4,0)
 ;;=3D4^V12.72
 ;;^UTILITY(U,$J,358.3,7945,1,5,0)
 ;;=3D5^Personal h/o Colon Polyps
 ;;^UTILITY(U,$J,358.3,7945,2)
 ;;=3D^303401
 ;;^UTILITY(U,$J,358.3,7946,0)
 ;;=3DV12.59^^65^553^49
 ;;^UTILITY(U,$J,358.3,7946,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7946,1,4,0)
 ;;=3D4^V12.59
 ;;^UTILITY(U,$J,358.3,7946,1,5,0)
 ;;=3D5^Personal h/o Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,7946,2)
 ;;=3D^303399
 ;;^UTILITY(U,$J,358.3,7947,0)
 ;;=3DV45.81^^65^553^50
 ;;^UTILITY(U,$J,358.3,7947,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7947,1,4,0)
 ;;=3D4^V45.81
 ;;^UTILITY(U,$J,358.3,7947,1,5,0)
 ;;=3D5^Personal h/o Coronary Bypass
 ;;^UTILITY(U,$J,358.3,7947,2)
 ;;=3D^97129
 ;;^UTILITY(U,$J,358.3,7948,0)
 ;;=3DV15.84^^65^553^51
 ;;^UTILITY(U,$J,358.3,7948,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7948,1,4,0)
 ;;=3D4^V15.84
 ;;^UTILITY(U,$J,358.3,7948,1,5,0)
 ;;=3D5^Personal h/o Exposure To Asbestos
 ;;^UTILITY(U,$J,358.3,7948,2)
 ;;=3D^303406
 ;;^UTILITY(U,$J,358.3,7949,0)
 ;;=3DV15.85^^65^553^55
 ;;^UTILITY(U,$J,358.3,7949,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7949,1,4,0)
 ;;=3D4^V15.85
 ;;^UTILITY(U,$J,358.3,7949,1,5,0)
 ;;=3D5^Personal h/o Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,7949,2)
 ;;=3D^303407
 ;;^UTILITY(U,$J,358.3,7950,0)
 ;;=3DV10.72^^65^553^53
 ;;^UTILITY(U,$J,358.3,7950,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7950,1,4,0)
 ;;=3D4^V10.72
 ;;^UTILITY(U,$J,358.3,7950,1,5,0)
 ;;=3D5^Personal h/o Hodgkin's Disease
 ;;^UTILITY(U,$J,358.3,7950,2)
 ;;=3D^295237
 ;;^UTILITY(U,$J,358.3,7951,0)
 ;;=3DV15.3^^65^553^54
 ;;^UTILITY(U,$J,358.3,7951,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7951,1,4,0)
 ;;=3D4^V15.3
 ;;^UTILITY(U,$J,358.3,7951,1,5,0)
 ;;=3D5^Personal h/o Irradiation
 ;;^UTILITY(U,$J,358.3,7951,2)
 ;;=3D^295285
 ;;^UTILITY(U,$J,358.3,7952,0)
 ;;=3DV10.61^^65^553^29
 ;;^UTILITY(U,$J,358.3,7952,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7952,1,4,0)
 ;;=3D4^V10.61
 ;;^UTILITY(U,$J,358.3,7952,1,5,0)
 ;;=3D5^Hx of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,7952,2)
 ;;=3DHx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,7953,0)
 ;;=3DV12.03^^65^553^30
 ;;^UTILITY(U,$J,358.3,7953,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7953,1,4,0)
 ;;=3D4^V12.03
 ;;^UTILITY(U,$J,358.3,7953,1,5,0)
 ;;=3D5^Hx of Malaria
 ;;^UTILITY(U,$J,358.3,7953,2)
 ;;=3DHx of Malaria^303395
 ;;^UTILITY(U,$J,358.3,7954,0)
 ;;=3DV10.82^^65^553^31
 ;;^UTILITY(U,$J,358.3,7954,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7954,1,4,0)
 ;;=3D4^V10.82
 ;;^UTILITY(U,$J,358.3,7954,1,5,0)
 ;;=3D5^Hx of Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,7954,2)
 ;;=3DHx of Malignant Melanoma^295240
